Literature DB >> 16545628

Idiopathic pulmonary fibrosis: natural history and prognosis.

Paul W Noble1.   

Abstract

Idiopathic pulmonary fibrosis (IPF) is associated with a poor prognosis, although considerable interpatient heterogeneity may be observed. Baseline dyspnea, lung function abnormalities, and gas exchange impairments are predictive of outcome, but recent evidence suggests the change in these parameters over time is as predictive, and in some cases more predictive, of outcome. A change in forced vital capacity > or =10% may be an important surrogate marker for mortality risk in IPF patients. Histologic analysis shows the deposition of interstitial connective tissue and granulation tissue leading to formation of fibroblastic foci. Thus, ongoing epithelial damage and repair processes associated with persistent fibroblastic proliferation seem important in IPF natural history.

Entities:  

Mesh:

Year:  2006        PMID: 16545628     DOI: 10.1016/j.ccm.2005.08.003

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  23 in total

1.  Low α(2)β(1) integrin function enhances the proliferation of fibroblasts from patients with idiopathic pulmonary fibrosis by activation of the β-catenin pathway.

Authors:  Hong Xia; Jeremy Seeman; Jian Hong; Polla Hergert; Vidya Bodem; Jose Jessurun; Karen Smith; Richard Nho; Judy Kahm; Philippe Gaillard; Craig Henke
Journal:  Am J Pathol       Date:  2012-05-27       Impact factor: 4.307

2.  miR-9-5p suppresses pro-fibrogenic transformation of fibroblasts and prevents organ fibrosis by targeting NOX4 and TGFBR2.

Authors:  Marta Fierro-Fernández; Óscar Busnadiego; Pilar Sandoval; Cristina Espinosa-Díez; Eva Blanco-Ruiz; Macarena Rodríguez; Héctor Pian; Ricardo Ramos; Manuel López-Cabrera; Maria Laura García-Bermejo; Santiago Lamas
Journal:  EMBO Rep       Date:  2015-08-27       Impact factor: 8.807

3.  miR-210 promotes IPF fibroblast proliferation in response to hypoxia.

Authors:  Vidya Bodempudi; Polla Hergert; Karen Smith; Hong Xia; Jeremy Herrera; Mark Peterson; Wajahat Khalil; Judy Kahm; Peter B Bitterman; Craig A Henke
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-06-20       Impact factor: 5.464

4.  ROCK and Rho: Promising therapeutic targets to ameliorate pulmonary fibrosis.

Authors:  David W H Riches; Donald S Backos; Elizabeth F Redente
Journal:  Am J Pathol       Date:  2015-02-14       Impact factor: 4.307

5.  Identification of a cell-of-origin for fibroblasts comprising the fibrotic reticulum in idiopathic pulmonary fibrosis.

Authors:  Hong Xia; Vidya Bodempudi; Alexey Benyumov; Polla Hergert; Damien Tank; Jeremy Herrera; Jeff Braziunas; Ola Larsson; Matthew Parker; Daniel Rossi; Karen Smith; Mark Peterson; Andrew Limper; Jose Jessurun; John Connett; David Ingbar; Sem Phan; Peter B Bitterman; Craig A Henke
Journal:  Am J Pathol       Date:  2014-03-13       Impact factor: 4.307

6.  Inhibition of pulmonary fibrosis in mice by CXCL10 requires glycosaminoglycan binding and syndecan-4.

Authors:  Dianhua Jiang; Jiurong Liang; Gabriele S Campanella; Rishu Guo; Shuang Yu; Ting Xie; Ningshan Liu; Yoosun Jung; Robert Homer; Eric B Meltzer; Yuejuan Li; Andrew M Tager; Paul F Goetinck; Andrew D Luster; Paul W Noble
Journal:  J Clin Invest       Date:  2010-05-17       Impact factor: 14.808

7.  Calcium-binding protein S100A4 confers mesenchymal progenitor cell fibrogenicity in idiopathic pulmonary fibrosis.

Authors:  Hong Xia; Adam Gilbertsen; Jeremy Herrera; Emilian Racila; Karen Smith; Mark Peterson; Timothy Griffin; Alexey Benyumov; Libang Yang; Peter B Bitterman; Craig A Henke
Journal:  J Clin Invest       Date:  2017-05-22       Impact factor: 14.808

Review 8.  Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders.

Authors:  Sonsoles Piera-Velazquez; Zhaodong Li; Sergio A Jimenez
Journal:  Am J Pathol       Date:  2011-07-19       Impact factor: 4.307

9.  Hyaluronan synthase 2 regulates fibroblast senescence in pulmonary fibrosis.

Authors:  Yuejuan Li; Jiurong Liang; Ting Yang; Jessica Monterrosa Mena; Caijuan Huan; Ting Xie; Adrianne Kurkciyan; Ningshan Liu; Dianhua Jiang; Paul W Noble
Journal:  Matrix Biol       Date:  2016-03-15       Impact factor: 11.583

10.  Laser capture microdissection reveals dose-response of gene expression in situ consequent to asbestos exposure.

Authors:  Qi Yin; Arnold R Brody; Deborah E Sullivan
Journal:  Int J Exp Pathol       Date:  2007-12       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.